diabetes

Lixisenatide NDA Withdrawn by Sanofi
Yahoo/Zacks
Sat, 09/14/13 - 10:52 am
lixisenatide
Sanofi
type 2 diabetes
diabetes
Biodel: Creating A Better, Faster Acting Insulin, The Next Big Thing For Diabetic Therapy
Seeking Alpha
Thu, 09/12/13 - 11:39 am
Biodel
insulin
diabetes
BIOD-123
Will History Repeat for Inhaled Insulin?
Motley Fool
Thu, 09/12/13 - 08:03 am
inhaled insulin
Afrezza
MannKind
diabetes
Sanofi Pulls U.S. File for Lixisenatide Diabetes Drug
Bloomberg
Thu, 09/12/13 - 08:00 am
diabetes
lixisenatide
Sanofi
Elixa
China's Diabetes Market Could Become A Big Focus For Pharma Companies
Seeking Alpha
Wed, 09/11/13 - 11:23 am
China
diabetes
JNJ
Merck
Pfizer
Novo Nordisk Pushes Ahead In Challenging Year
Investors.com
Tue, 09/10/13 - 04:48 pm
Novo Nordisk
Sanofi
Bristol-Myers Squibb
diabetes
Eli Lilly
MannKind
Biodel's BIOD-123 Achieves Primary Endpoint in Phase 2 Clinical Trial Demonstrating Glycemic Control Comparable to Humalog(R)
Yahoo
Mon, 09/9/13 - 09:52 am
Biodel
BIOD-123
clinical trials
diabetes
type 1 diabetes
Lawsuit Alleges Takeda Pharmaceutical Co., Maker Of Diabetes Drug Actos, Didn’t Warn Of The Drug’s Risks Soon Enough; Parker Waichman LLP Responds
Daily Markets
Sun, 09/8/13 - 11:14 am
Takeda
lawsuits
diabetes
Actos
Another Prize Slips Through Novo's Hands As Big PBM Looks Elsewhere
Seeking Alpha
Thu, 09/5/13 - 08:24 am
Novo Nordisk
diabetes
Takeda Put Actos Sales Ahead of Consumer Safety, Lawyer Says
Bloomberg
Wed, 09/4/13 - 09:05 am
Takeda
Actos
bladder cancer
diabetes
AstraZeneca Reports Onglyza Data
Yahoo/Zacks
Wed, 09/4/13 - 08:57 am
Onglyza
AstraZeneca
diabetes
Is 'No Worse Than Placebo' Good Enough For New Diabetes Drugs?
Forbes
Tue, 09/3/13 - 11:07 am
diabetes
saxagliptin
alogliptin
AstraZeneca
Bristol-Myers Squibb
Takeda
Is This a MannKind Killer?
Motley Fool
Tue, 09/3/13 - 09:54 am
MannKind
diabetes
Afrezza
BIOD-123
insulin
Biodel
Zealand Pharma, Eli Lilly sign obesity, diabetes research deal
Reuters
Thu, 08/29/13 - 09:31 am
Eli Lilly
Zealand Pharma
obesity
diabetes
R&D
3 PDUFA Dates That Will Kick Off 2014
Motley Fool
Tue, 08/27/13 - 05:34 pm
FDA
diabetes
Forixga
Bristol-Myers Squibb
AstraZeneca
Biomarin
Vimizim
Amylin
metreleptin
Antipsychotics Can Triple The Risk That Children Develop Diabetes
Pharmalot
Fri, 08/23/13 - 09:29 am
diabetes
antipsychotics
3 New Diabetes Drugs Possibly on the Way Soon
Motley Fool
Wed, 08/21/13 - 09:03 am
diabetes
Forixga
AstraZeneca
Bristol-Myers Squibb
dulaglutide
Eli Lilly
Afrezza
MannKind
MannKind's Steady Progression Towards FDA Approval Continues Unabated
Seeking Alpha
Mon, 08/19/13 - 09:43 am
MannKind
FDA
Afrezza
diabetes
insulin
inhaled insulin
Eli Lilly
Pfizer
Novo Nordisk
A Closer Look at 3 Players in Diabetes Treatments
Motley Fool
Sat, 08/17/13 - 10:55 am
type 2 diabetes
type 1 diabetes
Osiris Therapeutics
MannKind
diabetes
NovoNordisk
Positive Data on MannKind's Afrezza
Yahoo/Zacks
Sat, 08/17/13 - 10:38 am
MannKind
diabetes
Afrezza
type 2 diabetes

Pages